Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory to Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02566304
What this trial is testing

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionAplastic Anemia+12 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35
Large-scale testing (Phase 3)Ended earlyNCT03335059
What this trial is testing

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.

Who this might be right for
Bladder CancerBladder NeoplasmBladder Tumors+8 more
Medical Enterprises Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT00002508
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor
Temple University
Testing effectiveness (Phase 2)UnknownNCT00550810
What this trial is testing

Sutent Maintenance After Response to Taxotere

Who this might be right for
Prostate CancerHormone Refractory
Alberta Health services 30
Testing effectiveness (Phase 2)Study completedNCT03274882
What this trial is testing

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 26
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Large-scale testing (Phase 3)UnknownNCT02238873
What this trial is testing

Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma

Who this might be right for
LymphomaNeutropenia
Rabin Medical Center 300
Large-scale testing (Phase 3)Study completedNCT00003341
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+1 more
Memorial Sloan Kettering Cancer Center 275
Early research (Phase 1)Study completedNCT03086642
What this trial is testing

Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Karie D. Runcie, MD 10
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Large-scale testing (Phase 3)WithdrawnNCT03717038
What this trial is testing

Sym004 Versus TAS-102 in Patients With mCRC

Who this might be right for
Metastatic Colorectal CancerColorectal Cancer MetastaticCarcinoma
Symphogen A/S
Testing effectiveness (Phase 2)Ended earlyNCT03860844
What this trial is testing

Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Sanofi 67
Large-scale testing (Phase 3)Study completedNCT00661999
What this trial is testing

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 502
Large-scale testing (Phase 3)Ended earlyNCT01232556
What this trial is testing

Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

Who this might be right for
Lymphoma, Non-Hodgkin
Pfizer 338
Large-scale testing (Phase 3)Study completedNCT00639327
What this trial is testing

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Japan Clinical Cancer Research Organization 300
Large-scale testing (Phase 3)Ended earlyNCT01659658
What this trial is testing

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Systemic Light Chain Amyloidosis
Millennium Pharmaceuticals, Inc. 177
Testing effectiveness (Phase 2)Study completedNCT00025155
What this trial is testing

Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04098081
What this trial is testing

1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic Cancer
University of Maryland, Baltimore 15
Testing effectiveness (Phase 2)UnknownNCT02652910
What this trial is testing

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more
Xinqiao Hospital of Chongqing 20
Early research (Phase 1)Active Not RecruitingNCT02146924
What this trial is testing

Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
City of Hope Medical Center 71
Next Page